Intensifying glycaemic control with insulin reduces adiponectin and its HMW isoform moderately in type 2, but not in type 1, diabetes

Diabetes Metab. 2011 Jun;37(3):259-61. doi: 10.1016/j.diabet.2010.12.001. Epub 2011 Feb 8.

Abstract

Introduction: As the impact of diabetes control was not tested on adiponectin (ADPN) levels, this study was designed to assess whether or not controlling hyperglycaemia can affect ADPN.

Patients and methods: A total of 15 T1D and 48 T2D patients with HbA(1c) greater than 10% were studied at the time of hospitalization for uncontrolled diabetes. Total, and high-, medium- and low-molecular-weight (HMW, MMW, LMW) ADPN were measured at the time of study inclusion, on days 1 and 8, and at 1, 3 and 6 months after insulin treatment.

Results: While diabetes control improved, total and HMW APDN decreased on days 1 and 8, but remained steady thereafter in T2D patients. In T1D patients, ADPN levels remained unchanged throughout the study.

Conclusion: Glycaemic control with insulin reduces ADPN in T2D patients in the short-term, but was ineffective in T1D.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood*
  • Adult
  • Aged
  • Blood Glucose / metabolism*
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glycated Hemoglobin
  • Humans
  • Insulin / therapeutic use*
  • Male
  • Middle Aged
  • Protein Isoforms

Substances

  • Adiponectin
  • Blood Glucose
  • Glycated Hemoglobin A
  • Insulin
  • Protein Isoforms
  • hemoglobin A1c protein, human